CA2019797A1 - Methode et compose pour le traitement des maux de tete et des troubles nasaux - Google Patents
Methode et compose pour le traitement des maux de tete et des troubles nasauxInfo
- Publication number
- CA2019797A1 CA2019797A1 CA 2019797 CA2019797A CA2019797A1 CA 2019797 A1 CA2019797 A1 CA 2019797A1 CA 2019797 CA2019797 CA 2019797 CA 2019797 A CA2019797 A CA 2019797A CA 2019797 A1 CA2019797 A1 CA 2019797A1
- Authority
- CA
- Canada
- Prior art keywords
- solution
- composition
- suspension
- effective amount
- therapeutically effective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 13
- 206010019233 Headaches Diseases 0.000 title claims abstract description 9
- 231100000869 headache Toxicity 0.000 title claims abstract description 9
- 208000026344 Nasal disease Diseases 0.000 title claims 2
- 208000030880 Nose disease Diseases 0.000 title claims 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 claims abstract description 48
- 229960002504 capsaicin Drugs 0.000 claims abstract description 24
- 235000017663 capsaicin Nutrition 0.000 claims abstract description 24
- 230000000699 topical effect Effects 0.000 claims abstract description 11
- 239000000739 antihistaminic agent Substances 0.000 claims abstract description 7
- 239000003589 local anesthetic agent Substances 0.000 claims abstract description 7
- 150000003431 steroids Chemical class 0.000 claims abstract description 7
- 208000024891 symptom Diseases 0.000 claims abstract description 7
- 239000000725 suspension Substances 0.000 claims abstract 13
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims abstract 6
- 230000001387 anti-histamine Effects 0.000 claims abstract 6
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 claims description 7
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 6
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims description 5
- 229960004194 lidocaine Drugs 0.000 claims description 5
- 229960005274 benzocaine Drugs 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 229960004311 betamethasone valerate Drugs 0.000 claims description 3
- SNHRLVCMMWUAJD-SUYDQAKGSA-N betamethasone valerate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-SUYDQAKGSA-N 0.000 claims description 3
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims description 3
- 229960000520 diphenhydramine Drugs 0.000 claims description 3
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical group C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 claims description 3
- 229960005426 doxepin Drugs 0.000 claims description 3
- 230000000172 allergic effect Effects 0.000 claims description 2
- 208000010668 atopic eczema Diseases 0.000 claims description 2
- 208000027866 inflammatory disease Diseases 0.000 claims description 2
- 229960000890 hydrocortisone Drugs 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 8
- 210000001331 nose Anatomy 0.000 description 5
- 206010041232 sneezing Diseases 0.000 description 5
- 239000006196 drop Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 235000002566 Capsicum Nutrition 0.000 description 3
- 241000722363 Piper Species 0.000 description 3
- 206010039085 Rhinitis allergic Diseases 0.000 description 3
- 201000010105 allergic rhinitis Diseases 0.000 description 3
- 229940100662 nasal drops Drugs 0.000 description 3
- 229940100656 nasal solution Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010052437 Nasal discomfort Diseases 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 229960000631 hydrocortisone valerate Drugs 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 208000001319 vasomotor rhinitis Diseases 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000036975 Ambrosia artemisiifolia Species 0.000 description 1
- 235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010051496 Rhinalgia Diseases 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
- 229960000836 amitriptyline Drugs 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 235000003484 annual ragweed Nutrition 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000006263 bur ragweed Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000003488 common ragweed Nutrition 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 235000009736 ragweed Nutrition 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 208000018316 severe headache Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2019797 CA2019797A1 (fr) | 1990-06-26 | 1990-06-26 | Methode et compose pour le traitement des maux de tete et des troubles nasaux |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2019797 CA2019797A1 (fr) | 1990-06-26 | 1990-06-26 | Methode et compose pour le traitement des maux de tete et des troubles nasaux |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2019797A1 true CA2019797A1 (fr) | 1991-12-26 |
Family
ID=4145331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2019797 Abandoned CA2019797A1 (fr) | 1990-06-26 | 1990-06-26 | Methode et compose pour le traitement des maux de tete et des troubles nasaux |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2019797A1 (fr) |
-
1990
- 1990-06-26 CA CA 2019797 patent/CA2019797A1/fr not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5008289A (en) | Composition for treating nasal disorders and headaches | |
| US5134166A (en) | Method for treating nasal disorders and headaches | |
| US4997853A (en) | Method and compositions utilizing capsaicin as an external analgesic | |
| AU651089B2 (en) | Treatment of sinus headache | |
| US5063060A (en) | Compositions and method for treating painful, inflammatory or allergic disorders | |
| US5116852A (en) | Treatment of sleep disorders | |
| DE69428268D1 (de) | Verwendung von lokalanaesthetika zur herstellung eines arzneimittels zur behandlung von bronchialasthma | |
| KR20090080017A (ko) | 건조각막결막염 경감 방법 | |
| EP1231920A1 (fr) | Solutions contenant de l'epinastine | |
| WINTER et al. | The effect of androgenic hormones upon the adrenal atrophy produced by cortisone injections and upon the antiinflammatory action of cortisone | |
| Tattersfield | Clinical pharmacology of long-acting β-receptor agonists | |
| US4395420A (en) | Method and composition for treating pruritis | |
| AU3774893A (en) | 5-ht2 receptor antagonist compositions useful in treating venous conditions | |
| CA2019797A1 (fr) | Methode et compose pour le traitement des maux de tete et des troubles nasaux | |
| US5331012A (en) | Topical pharmaceutical preparation for fever blisters and other viral infections and method of use | |
| EP0458661B1 (fr) | Application thérapeutique d'agonistes du récepteur H3 de l'histamine, nouveaux composés et utilisation pour la préparation de médicaments | |
| Seifter et al. | Oxethazaine and related congeners: a series of highly potent local anesthetics. | |
| JP2003518506A (ja) | 精製蟾酥エキスを用いて勃起性陰萎を予防および治療するための薬剤組成物 | |
| JPH07277988A (ja) | 局所用掻痒除去、治療剤 | |
| US4315024A (en) | Compositions and method for treating red eye | |
| JPH05286860A (ja) | ゲル軟膏剤 | |
| EP1148883B1 (fr) | Utilisation des antidepresseurs tricycliques pour le traitement des maux de tete | |
| EP0818987B1 (fr) | Composition et procede de prevention et de traitement des reactions anaphylactiques cutanees immediates | |
| US4829068A (en) | Treatment of disorders of the gastro-intestinal tract | |
| US5686095A (en) | Method of treating canker sores |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |